<< Back To Search

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
This study is trying to find out if a medicine called romosozumab is safe and helpful for people who are postmenopausal and have a bone disease called osteoporosis or a cancer called multiple myeloma. They want to see if it helps bones grow and also stops them from breaking down too much.
*Third Opinion AI Generated Synopsis

Trial Summary
The purpose of this study is to measure the effect of romosozumab on bone formation and breakdown (resorption) and determine if romosozumab is a safe treatment for osteoporosis and myeloma-related bone disease (MBD) in postmenopausal people with multiple myeloma (MM).

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?